Serum microRNAs as biomarkers of human lymphocyte activation in health and disease

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  de Candia, Paola ^a   Torri, Anna ^a   Pagani, Massimiliano ^a   Abrignani, Sergio ^a  

^a Istituto Nazionale di Genetica Molecolare   (Italy)

Author keywords

Circulating microRNAs; Exosomes; T lymphocytes; Vaccination

Indexed keywords

INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; MICRORNA 150; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DOWN REGULATION; EXOSOME; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLUENZA A (H1N1); LYMPHOCYTE; NONHUMAN; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; VACCINATION;

EID: 84895557967     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00043     Document Type: Short Survey

References (43)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell (2009) 136:215-33. doi:10.1016/j.cell.2009.01.002.
2. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 18:997-1006. doi:10.1038/cr.2008.282.
3. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 108:5003-8. doi:10.1073/pnas.1019055108.
4. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 105:10513-8. doi:10.1073/pnas.0804549105.
5. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A (2011) 108:3713-8. doi:10.1073/pnas.1100048108.
6. Moussay E, Wang K, Cho JH, van Moer K, Pierson S, Paggetti J, et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2011) 108:6573-8. doi:10.1073/pnas.1019557108.
7. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 110:13-21. doi:10.1016/j.ygyno.2008.04.033.
8. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 31:2765-73. doi:10.1093/eurheartj/ehq167.
9. Goretti E, Vausort M, Wagner DR, Devaux Y. Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarction. Int J Cardiol (2013) 168:4548-50. doi:10.1016/j.ijcard.2013.06.092.
10. Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol (2013) 9:513-21. doi:10.1038/nrendo.2013.86.
11. Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology (2011) 54:1767-76. doi:10.1002/hep.24538.
12. Chen YJ, Zhu JM, Wu H, Fan J, Zhou J, Hu J, et al. Circulating microRNAs as a fingerprint for liver cirrhosis. PLoS One (2013) 8:e66577. doi:10.1371/journal.pone.0066577.
13. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun (2010) 394:184-8. doi:10.1016/j.bbrc.2010.02.145.
14. Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, et al. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One (2013) 8:e54612. doi:10.1371/journal.pone.0054612.
15. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol (2011) 80:193-208. doi:10.1016/j.critrevonc.2010.11.004.
16. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. Traffic (2002) 3:321-30. doi:10.1034/j.1600-0854.2002.30502.x.
17. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 200:373-83. doi:10.1083/jcb.201211138.
18. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 13:423-33. doi:10.1038/ncb2210.
19. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 9:654-9. doi:10.1038/ncb1596.
20. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 9:581-93. doi:10.1038/nri2567.
21. Bobrie A, Colombo M, Raposo G, Thery C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic (2011) 12:1659-68. doi:10.1111/j.1600-0854.2011.01225.x.
22. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med (1996) 183:1161-72. doi:10.1084/jem.183.3.1161.
23. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol (2002) 168:3235-41.
24. Taylor DD, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol (2006) 176:1534-42.
25. Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol (2009) 21:575-81. doi:10.1016/j.ceb.2009.03.007.
26. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell (2009) 136:26-36. doi:10.1016/j.cell.2008.12.027.
27. Bronevetsky Y, Ansel KM. Regulation of miRNA biogenesis and turnover in the immune system. Immunol Rev (2013) 253:304-16. doi:10.1111/imr.12059.
28. Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, González S, Sánchez-Cabo F, González Má, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun (2011) 2:282. doi:10.1038/ncomms1285.
29. Gutierrez-Vazquez C, Villarroya-Beltri C, Mittelbrunn M, Sanchez-Madrid F. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev (2013) 251:125-42. doi:10.1111/imr.12013.
30. Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adh Migr (2007) 1:156-8. doi:10.4161/cam.1.3.5114.
31. Nolte-'t Hoen EN, Buermans HP, Waasdorp M, Stoorvogel W, Wauben MH, 't Hoen PA. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res (2012) 40:9272-85. doi:10.1093/nar/gks658.
32. de Candia P, Torri A, Gorletta T, Fedeli M, Bulgheroni E, Cheroni C, et al. Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS One (2013) 8:e75348. doi:10.1371/journal.pone.0075348.
33. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal RJ, et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol (2011) 12:796-803. doi:10.1038/ni.2057.
34. Pagani M, Rossetti G, Panzeri I, de Candia P, Bonnal RJ, Rossi RL, et al. Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation. Immunol Rev (2013) 253:82-96. doi:10.1111/imr.12055.
35. Plotkin SA, Orenstein W, Offit PA. Vaccines. 6th ed. Saunders (2013).
36. He Y, Jiang X, Chen J. The role of miR-150 in normal and malignant hematopoiesis. Oncogene (2013). doi:10.1038/onc.2013.346.
37. Monticelli S, Ansel KM, Xiao C, Socci ND, Krichevsky AM, Thai TH, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol (2005) 6:R71. doi:10.1186/gb-2005-6-8-r71.
38. Salomoni P, Perrotti D, Martinez R, Franceschi C, Calabretta B. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proc Natl Acad Sci U S A (1997) 94:3296-301. doi:10.1073/pnas.94.7.3296.
39. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell (2007) 131:146-59. doi:10.1016/j.cell.2007.07.021.
40. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood (2011) 117:7053-62. doi:10.1182/blood-2010-12-326629.
41. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 253:1417-20. doi:10.1126/science.1910207.
42. Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J (2009) 28:563-71. doi:10.1097/INF.0b013e31819d6394.
43. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer (2009) 10:42-6. doi:10.3816/CLC.2009.n.006.